Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 4, 2006

View Archived Issues

Recent GE patent discloses novel diagnostic agents

Novel therapeutic agents for nephrotoxicity developed at Hiroshima University

Recent patents describe novel therapeutic agents for psychosis, depression, sleep disorders, etc.

New antiviral agents disclosed in recent patent literature

Suven Life Sciences and Lilly to identify GPCR modulators for CNS disorders

Sankyo and Ajinomoto sign license agreement for diabetes compound AJD-101

Sanofi-aventis extends research collaboration with ImmunoGen

Exelixis submits IND for XL-228

Dyax receives FDA guidance on BLA pathway for DX-88

International Trade Commission rules in Roche's favor for Mircera

Ark files response to EMEA for Cerepro

Aktiv-Dry awarded grant to develop inhalable nicotine vaccine

ACE-393 vaccine against C. jejuni begins phase I

ADX-10059 begins phase II program

Pluristem awarded Israeli grant for stem cell product PLX-1

Preliminary results from phase I study of RAV-12 in adenocarcinomas

Tecadenoson protective against myocardial stunning

Cardioprotective effects of eNOS enhancement

Positive phase II data reported for NV1FGF in critical limb ischemia

Promising efficacy for a novel ragweed immunotherapy vaccine

Preliminary evidence for bronchodilating activity of TPI-1020

Evaluation of ACZ-885 in healthy subjects and mild asthmatics

GSK reports on new LRH-1 agonist for therapeutic assessment in cardiovascular disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...